The Paris system classification for urinary cytology in patients under bacillus Calmette‐Guerin treatment
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24952
Abstract: The role of urinary cytology as a diagnostic test for the detection and surveillance of urothelial cancer is crucial. Intravesical bacillus Calmette‐Guerin (BCG) is the appropriate therapeutic strategy for patients with high‐grade urothelial carcinoma (HGCU)… read more here.
Keywords: paris system; cytology patients; calmette guerin; bacillus calmette ... See more keywords
Mycobacterium bovis infection of total hip arthroplasty after intravesicular Bacillus Calmette-Guérin
Sign Up to like & getrecommendations! Published in 2019 at "Arthroplasty Today"
DOI: 10.1016/j.artd.2019.08.004
Abstract: Intravesicular application of Bacillus Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is effective in the treatment of bladder cancer. However, systemic dissemination and subsequent infection of implants have been reported. We present a… read more here.
Keywords: bovis infection; mycobacterium bovis; infection; bovis ... See more keywords
Regression of the Sweet's syndrome after Bacillus Calmette-Guérin therapy: A bladder cancer case report
Sign Up to like & getrecommendations! Published in 2020 at "Urology Case Reports"
DOI: 10.1016/j.eucr.2020.101202
Abstract: The Sweet's syndrome is a rare dermatosis which can be related to underlying malignancies. In this case we presented a case, who applied to our clinic with severe dermatosis and hematuria. We diagnosed high grade… read more here.
Keywords: sweet syndrome; rin therapy; bladder; case ... See more keywords
Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.06.018
Abstract: Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non-muscle-invasive bladder cancer. Primary producers of BCG announced shortages within the last decade, leading to a worldwide shortage. We review the literature… read more here.
Keywords: bacillus calmette; shortage; manufacturing market; calmette rin ... See more keywords
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle invasive Bladder Cancer: Con.
Sign Up to like & getrecommendations! Published in 2021 at "European urology focus"
DOI: 10.1016/j.euf.2021.09.005
Abstract: The use of sequential intravesical instillation of gemcitabine and docetaxel in the management of bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer should not be recommended as a second-line treatment. First, technical issues are a barrier to broad… read more here.
Keywords: rin unresponsive; muscle invasive; unresponsive non; non muscle ... See more keywords
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
Sign Up to like & getrecommendations! Published in 2020 at "European Urology"
DOI: 10.1016/j.eururo.2020.08.027
Abstract: Take Home Message Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor… read more here.
Keywords: bacillus calmette; mechanism; calmette rin;
Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"
DOI: 10.1016/j.jctube.2020.100152
Abstract: Vascular bypass graft infection with Mycobacterium bovis following Bacillus Calmette–Guérin (BCG) immunotherapy for bladder cancer is an incredibly rare complication. We present the case of an 85-year-old man with a history of femorofemoral bypass who… read more here.
Keywords: bypass; mycobacterium bovis; graft; bacillus calmette ... See more keywords
Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer's disease?
Sign Up to like & getrecommendations! Published in 2019 at "Medical hypotheses"
DOI: 10.1016/j.mehy.2019.01.007
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder which is the most prevalent cause of dementia in the western world. Currently, it is the most expensive disease in America, costing more than heart diseases and cancer… read more here.
Keywords: disease; bacillus calmette; calmette rin; bcg ... See more keywords
Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin for High-grade Non-muscle-invasive Bladder Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Urology"
DOI: 10.1016/j.urology.2017.05.035
Abstract: A 47-year-old man presented to the urology department with visible hematuria. He was found to have a high-grade non-muscle-invasive transitional cell carcinoma of the bladder and was subsequently treated with intravesical Bacillus Calmette-Guérin instillations. On… read more here.
Keywords: high grade; muscle invasive; non muscle; bacillus calmette ... See more keywords
TRIM59: A membrane protein expressed on Bacillus Calmette-Guérin-activated macrophages that induces apoptosis of fibrosarcoma cells by direct contact.
Sign Up to like & getrecommendations! Published in 2019 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2019.111590
Abstract: Bacillus Calmette-Guérin (BCG)-activated macrophages (BAMs) have anti-tumor effects, especially on fibrosarcoma cells. However, the mechanism governing this process has not been elucidated to date. TRIM59 is an up-regulated membrane protein expressed on the surface of… read more here.
Keywords: activated macrophages; trim59; bacillus calmette; fibrosarcoma cells ... See more keywords
Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Investigation"
DOI: 10.1080/07357907.2018.1430815
Abstract: ABSTRACT There are few data on Bacillus Calmette-Guérin (BCG) therapy for upper urinary tract carcinoma in situ (UUT CIS). We retrospectively evaluated the efficacy and tolerability of BCG therapy for 41 patients [52 renal units(RUs)]… read more here.
Keywords: therapy upper; bacillus calmette; calmette rin; therapy ... See more keywords